172 related articles for article (PubMed ID: 11640930)
1. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
Wittekindt B; Malany S; Schemm R; Otvos L; Maccecchini ML; Laube B; Betz H
Neuropharmacology; 2001 Nov; 41(6):753-61. PubMed ID: 11640930
[TBL] [Abstract][Full Text] [Related]
2. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors.
Donevan SD; McCabe RT
Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
Klein RC; Galdzicki Z; Castellino FJ
Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
5. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
Sheng Z; Prorok M; Castellino FJ
Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides.
Klein RC; Warder SE; Galdzicki Z; Castellino FJ; Prorok M
Neuropharmacology; 2001 Dec; 41(7):801-10. PubMed ID: 11684144
[TBL] [Abstract][Full Text] [Related]
8. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.
Twede VD; Teichert RW; Walker CS; Gruszczyński P; Kaźmierkiewicz R; Bulaj G; Olivera BM
Biochemistry; 2009 May; 48(19):4063-73. PubMed ID: 19309162
[TBL] [Abstract][Full Text] [Related]
9. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
[TBL] [Abstract][Full Text] [Related]
10. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
Klein RC; Prorok M; Galdzicki Z; Castellino FJ
J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
[TBL] [Abstract][Full Text] [Related]
11. Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA.
Hammerland LG; Olivera BM; Yoshikami D
Eur J Pharmacol; 1992 Jul; 226(3):239-44. PubMed ID: 1358659
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
[TBL] [Abstract][Full Text] [Related]
13. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.
Xiao C; Huang Y; Dong M; Hu J; Hou S; Castellino FJ; Prorok M; Dai Q
Neuropeptides; 2008; 42(5-6):601-9. PubMed ID: 18992939
[TBL] [Abstract][Full Text] [Related]
14. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
15. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
Masuko T; Kashiwagi K; Kuno T; Nguyen ND; Pahk AJ; Fukuchi J; Igarashi K; Williams K
Mol Pharmacol; 1999 Jun; 55(6):957-69. PubMed ID: 10347236
[TBL] [Abstract][Full Text] [Related]
16. Effect of Conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons.
Alex AB; Baucum AJ; Wilcox KS
J Neurophysiol; 2006 Sep; 96(3):1084-92. PubMed ID: 16760339
[TBL] [Abstract][Full Text] [Related]
17. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site.
Zhou LM; Szendrei GI; Fossom LH; Maccecchini ML; Skolnick P; Otvos L
J Neurochem; 1996 Feb; 66(2):620-8. PubMed ID: 8592132
[TBL] [Abstract][Full Text] [Related]
18. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue.
Ronald KM; Mirshahi T; Woodward JJ
J Biol Chem; 2001 Nov; 276(48):44729-35. PubMed ID: 11572853
[TBL] [Abstract][Full Text] [Related]
19. Direct binding properties of conantokins to native N-methyl-d-aspartate receptors.
Klein RC; Prorok M; Castellino FJ
J Pept Res; 2003 Jun; 61(6):307-17. PubMed ID: 12753378
[TBL] [Abstract][Full Text] [Related]
20. NMDA-receptor antagonist requirements in conantokin-G.
Blandl T; Prorok M; Castellino FJ
FEBS Lett; 1998 Sep; 435(2-3):257-62. PubMed ID: 9762921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
